UBS analyst Radi Sultan raised the firm’s price target on Nutanix (NTNX) to $60 from $57 and keeps a Buy rating on the shares. Nutanix reported solid 2Q26 results, with a 1.1% Q2 revenue beat in line with expectations and a lower revenue/free cash flow outlook due to largely anticipated, timing-related CPU and memory constraints, more than offset by strong demand indicators including 16% year over year annual recurring revenue growth, 17% y/y cRPO growth, and the highest customer adds in eight years, the analyst tells investors in a research note. With only 20% penetration of the VMware (VMW) migration opportunity, the company appears positioned for durable mid-teens growth in FY27-FY28, and while some supply risk remains, guidance suggests only a modest constraint impact and limited risk of a further Q4 reset, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $50 from $57 at Wells Fargo
- Nutanix price target lowered to $47 from $53 at Barclays
- Nutanix: Strengthening Fundamentals, VMware Replacement Tailwinds, and AI Upside Support a Long-Term Buy Thesis
- Closing Bell Movers: Nvidia pares post-earnings gains
- AMD to invest $150M in Nutanix, announces agentic AI partnership
